PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

PET method offers new insight into inflammation of the brain
Researchers are hopeful that their technique could improve the diagnosis of conditions associated with neural inflammation.
New PET imaging method could improve our understanding of long COVID
Researchers have developed a new radiotracer that targets one of the virus’ spike proteins, allowing them to track it longitudinally.
FDA approves new prostate cancer imaging agent with extended shelf life
The new product from Telix paves the way for increased access at clinics where prostate PET may not have been available in the past.
New PET study offers insight into how dopamine drives executive function
These findings could help guide the development of new treatments for psychiatric and neurological disorders.
Bracco updates HeartSee coronary flow capacity software with new diagnostic features
Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

FAPI PET improves staging and clinical management for a significant portion of pancreatic cancers

Fibroblast activation protein inhibitor PET imaging may provide more accurate insight into the spread of pancreatic cancer than more commonly used 18F-FDG PET/CT.

Hall of Fame Health partnership set to advance study of neurodegeneration via new PET imaging agent

The organization is teaming up with CereMark Pharma to conduct research on improving outcomes in soldiers and athletes with neurodegenerative conditions.

Reducing prostate cancer treatment dosage alleviates downsides while remaining effective

Reducing certain treatments by around 25% and 50% still achieves promising PSA response rates, but reduces some of the unwanted side effects of therapy, like dry mouth.

COVID remnants still show up on PET/CT scans years after infection

That’s according to new PET imaging that shows the presence of activated T cells in the brain, spinal cord, gut and lung tissues of individuals who have recovered from COVID.

Frequent sleep disruptions may increase amyloid deposits down the road

Daily sleep disruptions could increase the risk of developing Alzheimer’s disease in the future, new research suggests.

Hearing aids help slow brain aging in individuals with mild cognitive impairment

Hearing aids help stall brain aging, new imaging study shows

For people with auditory impairment, hearing aid use could slow metabolic decline in regions of the brain associated with cognitive function.

stroke brain dementia alzheimer's puzzle mental health

Friends and family noticing differences in loved ones' memory could predict early changes in the brain

Experts recently uncovered strong associations between reports of memory loss from patients' peers/loved ones and the presence of tau tangles on imaging.

New Drug Application for PSMA-PET 'cold kit' could expand access to prostate imaging

If approved, the kit could allow for more flexible production of prostate cancer imaging agents.

PET/CT

PET method offers new insight into inflammation of the brain

New PET imaging method could improve our understanding of long COVID

FDA approves new prostate cancer imaging agent with extended shelf life

New PET study offers insight into how dopamine drives executive function

Bracco updates HeartSee coronary flow capacity software with new diagnostic features